Pegylated interferon alpha

BIOLOGICAL2 trials

Sponsors

Weill Medical College of Cornell University, Fremantle Hospital and Health Service

Conditions

Hepatitis C

Phase 1

Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I

TerminatedNCT00277758

Weill Medical College of Cornell UniversityHepatitis C

Start: 2004-03-31End: 2006-08-31Updated: 2008-03-07

Unknown Phase

In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia

CompletedNCT01726400

Fremantle Hospital and Health ServiceHepatitis C

Start: 2012-12-31End: 2014-07-31Updated: 2015-11-10

Related Papers

Dysregulated Erythropoietin, Hepcidin, and Bone Marrow Iron Metabolism Contribute to Interferon-Induced Anemia in Hepatitis C

Journal of Interferon & Cytokine Research2016-09-127 citations